Rita Jain - 03 Jan 2023 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role
Director
Signature
/s/ Thierry Chauche, as attorney-in-fact
Issuer symbol
PRVB
Transactions as of
03 Jan 2023
Transactions value $
$0
Form type
4
Filing time
05 Jan 2023, 15:31:08 UTC
Previous filing
24 Oct 2022
Next filing
21 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Award $0 +66,000 $0 66,000 03 Jan 2023 Common Stock, par value $0.0001 66,000 $9.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 3, 2023, the Reporting Person was granted a stock option for 66,000 shares of Common Stock which vests in equal installments every six months over a four-year period.
F2 The stock options were granted pursuant to the Provention Bio, Inc. 2017 Equity Incentive Plan.